Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|November 16, 2018
Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individualsGordon T Bolger, Albert Licollari, Amin Tan, et al.British Journal of Haematology|September 20, 2014
A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulinThomas Melchardt, Katharina Troppan, Lukas Weiss, et al.Anticancer Research|February 28, 2023
Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck CancerSandro M Wagner, Teresa Magnes, Thomas Melchardt, et al.European Journal of Haematology|December 16, 2019
Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomasSandro M Wagner, Thomas Melchardt, Alexander Egle, et al.Future Science OA|January 13, 2021
Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patientsKonstantin Schlick, Florian Hohla, Frank Hamacher, et al.Journal of Clinical Medicine|June 5, 2020
Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III TrialGabriel Rinnerthaler, Simon Peter Gampenrieder, Hubert Hackl, et al.Cancers|February 10, 2021
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous BiopsiesTeresa Magnes, Sandro Wagner, Aaron R Thorner, et al.Wiener Klinische Wochenschrift|September 16, 2021
Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMTTeresa Magnes, Sandro M Wagner, Thomas Melchardt, et al.European Journal of Haematology|February 7, 2019
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIMFlorian Huemer, Thomas Melchardt, Bettina Jansko, et al.European Journal of Cancer (Oxford, England : 1990)|February 26, 2018
Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study groupThomas Melchardt, Teresa Magnes, Clemens Hufnagl, et al.Pageof 3